IL17A and arthritic joint disease: The role of IL-17 in the development of CIA was first proved by the blockade of endogenous IL-17 with soluble IL-17 receptor protein in immunized DBA/1 mice [31], which resulted in the suppression of arthritis, accompanied by reduced joint damage.